Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors

SIMPLE SUMMARY: The impact of aspirin use after the diagnosis of colorectal cancer is unknown. Among others, PIK3CA mutational status was proposed as a molecular biomarker for the response to adjuvant aspirin therapy. The aim of this study was to retrospectively analyze whether the PIK3CA and KRAS m...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebauer, Leonie, Nist, Andrea, Mernberger, Marco, Stiewe, Thorsten, Moll, Roland, Stabla, Kathleen, Klinge, Uwe, Mack, Elisabeth, Brendel, Cornelia, Neubauer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507980/
https://www.ncbi.nlm.nih.gov/pubmed/34638442
http://dx.doi.org/10.3390/cancers13194959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507980/
https://www.ncbi.nlm.nih.gov/pubmed/34638442
http://dx.doi.org/10.3390/cancers13194959

Ejemplares similares